{
    "clinical_study": {
        "@rank": "116105", 
        "arm_group": {
            "arm_group_label": "Phasix Mesh", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "Collect data on safety, performance, and effectiveness of Phasix Mesh in subject requiring\n      primary ventral and incisional hernias."
        }, 
        "brief_title": "A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ventral Hernia", 
            "Incisional Hernia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hernia", 
                "Hernia, Ventral"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject or subject's legally authorized representative must be willing to give\n             written informed consent\n\n          -  Subject must be diagnosed with ventral or incisional hernia\n\n          -  Subject must be willing to undergo open ventral hernia repair and be able to undergo\n             all other study procedures as outlined in this protocol.\n\n        Exclusion Criteria:\n\n          -  Subject is an active smoker (if attempts to quit smoking within two weeks of surgery\n             have failed and the patient is still an active smoker at the time of surgery).\n\n          -  Subject's hernia has recurred more than once.\n\n          -  Subject's body mass index (BMI) >40 kg/m2.\n\n          -  Subject has peritonitis.\n\n          -  Subject is on or suspected to be placed on chemotherapy medications during any part\n             of the study.\n\n          -  Chronic steroid use or immunosuppression drugs (> 6 months).\n\n          -  Subject has cirrhosis, and/or ascites.\n\n          -  Subject is American Society of Anesthesiology Class 4 or 5.\n\n          -  Subject is pregnant or planning to become pregnant during the course of the study.\n\n          -  Subject is known to be infected with human immunodeficiency virus (HIV).\n\n          -  Subject has a life expectancy of less than 2 years at the time of enrollment.\n\n          -  Subject has been treated with an investigational product in the past 30 days.\n\n          -  Subject is part of the site personnel directly involved with this study\n\n          -  Subject has a known allergy to tetracycline hydrochloride or kanamycin sulfate, the\n             test device or its component materials.\n\n          -  Subject has any condition that in the opinion of the Investigator would preclude the\n             use of the study device, or preclude the subject from completing the follow-up\n             requirements"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02053168", 
            "org_study_id": "DVL-HE-015"
        }, 
        "intervention": {
            "arm_group_label": "Phasix Mesh", 
            "intervention_name": "Phasix Mesh", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Laura.sarmiento@cshs.org", 
                    "last_name": "Laura Sarmiento", 
                    "phone": "310-423-4295"
                }, 
                "facility": {
                    "address": {
                        "city": "Beverly Hills", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90210"
                    }, 
                    "name": "Beverly Hills Hernia Center"
                }, 
                "investigator": {
                    "last_name": "Shirin Towfigh, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Laura.sarmiento@cshs.org", 
                    "last_name": "Laura Sarmiento", 
                    "phone": "310-423-4295"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "Cedars-Sinai Medical Center"
                }, 
                "investigator": {
                    "last_name": "Shirin Towfigh, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Kim.cartwright@flhosp.org", 
                    "last_name": "Kim Cartwritght, RN", 
                    "phone": "407-303-4235"
                }, 
                "facility": {
                    "address": {
                        "city": "Celebration", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34747"
                    }, 
                    "name": "Florida Hospital Celebration Health"
                }, 
                "investigator": {
                    "last_name": "Eduardo Parra Davila, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Christina.seafler@uhhospitals.org", 
                    "last_name": "Christina Seafler, RN", 
                    "phone": "216-844-4706"
                }, 
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44106"
                    }, 
                    "name": "University Hospitals Case Medical Center"
                }, 
                "investigator": {
                    "last_name": "Yuri Novitsky, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Multicenter All Comers Study of a Novel Resorbable Mesh (Phasix Mesh) for Ventral or Incisional Hernia Repair", 
        "overall_contact": {
            "email": "rushil.sankpal@crbard.com", 
            "last_name": "Rushil Sankpal", 
            "phone": "908-277-8082"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Case Medical Center", 
            "last_name": "Yuri Novitsky, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hernia Recurrence Rate", 
            "safety_issue": "No", 
            "time_frame": "12 Months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02053168"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Device related adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "24 Months"
            }, 
            {
                "measure": "QOL assessments", 
                "safety_issue": "No", 
                "time_frame": "24 Months"
            }, 
            {
                "measure": "Surgical procedure time", 
                "safety_issue": "No", 
                "time_frame": "10 Months"
            }, 
            {
                "measure": "Length of hospital post Index Procedure", 
                "safety_issue": "No", 
                "time_frame": "10 Months"
            }, 
            {
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "10 Months"
            }, 
            {
                "measure": "Number of study related post operative surgical procedures and admissions.", 
                "safety_issue": "No", 
                "time_frame": "24 Months"
            }, 
            {
                "measure": "Number of study related post operative surgical procedure and admissions", 
                "safety_issue": "No", 
                "time_frame": "24 Months"
            }, 
            {
                "measure": "Number of related post-operative visits unrelated to standard of care", 
                "safety_issue": "No", 
                "time_frame": "24 Months"
            }, 
            {
                "measure": "Incidence of seroma", 
                "safety_issue": "No", 
                "time_frame": "24 Months"
            }
        ], 
        "source": "C. R. Bard", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "C. R. Bard", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}